| 摘要 |
<p>Oral pharmaceutical composition having anti-atherosclerotic activity comprise a 4-(monoalkylamino) benzoic acid of formula: <IMAGE> wherein n is an integer from 13 to 17, inclusive or a pharmacologically acceptable acid-addition or cationic salt thereof, together with a pharmaceutical carrier.</p> |
